Gemtuzumab Ozogamicin Injection

Generic name: Pronounced as (jem tooz' ue mab) (oh" zoe ga mye' sin)
Brand names
  • Mylotarg®
Click on drug name to hear pronunciation

Medical Content Reviewed By HelloPharmacist Staff

Last Revised - 08/15/2020

Gemtuzumab ozogamicin injection may cause severe or life-threatening liver damage, including hepatic veno-occlusive disease (VOD; blocked blood vessels inside the liver). Tell your doctor if you have or have ever had liver disease or have had a hematopoietic stem-cell transplant (HSCT; procedure that replaces diseased bone marrow with healthy bone marrow). If you experience any of the following symptoms, call your doctor immediately: rapid weight gain, pain or swelling in the upper right part of the stomach, yellowing of the skin or eyes, nausea, vomiting, dark colored urine, or extreme tiredness.

Keep all appointments with your doctor and the laboratory. Your doctor will order certain tests before, during, and after your treatment to check your body's response to gemtuzumab ozogamicin injection.

Talk to your doctor about the risks of taking gemtuzumab ozogamicin injection.

Gemtuzumab ozogamicin injection is used alone or in combination with other chemotherapy medications to treat a certain type of acute myeloid leukemia (AML; a type of cancer that begins in the white blood cells) in adults and children 1 month of age and older who were recently found to have this cancer. It is also used alone to treat a certain type of AML in adults and children 2 years of age and older whose cancer worsened during or after treatment with other chemotherapy medications. Gemtuzumab ozogamicin injection is in a class of medications called monoclonal antibodies. It works by helping to kill cancer cells.

Gemtuzumab ozogamicin injection comes as a powder to be mixed with liquid and given through a needle or catheter placed into a vein. It is usually injected slowly over a period of 2 hours. Your doctor will tell you how often you will receive gemtuzumab ozogamicin injection. The dosing schedule depends on if you are being treated with other chemotherapy medications, if your cancer was previously treated, and how your body responds to the medication.

Gemtuzumab ozogamicin injection may cause serious or life-threatening reactions during an infusion and for up to a day afterwards. You will receive certain medications to help prevent a reaction before you receive each dose of gemtuzumab ozogamicin. A doctor or nurse will watch you closely while you are receiving the infusion and shortly after the infusion to be sure you are not having a serious reaction to the medication. Tell your doctor or nurse immediately if you experience any of the following symptoms that may occur during or within 24 hours after the infusion: rash, fever, chills, fast heartbeat, swollen tongue or throat, shortness of breath or difficulty breathing.

Your doctor may slow down your infusion, delay, or stop your treatment with gemtuzumab ozogamicin injection, or treat you with additional medications depending on your response to the medication and any side effects that you experience. Talk to your doctor about how you are feeling during and after your treatment.

This medication may be prescribed for other uses; ask your doctor or pharmacist for more information.

Before receiving gemtuzumab ozogamicin injection,

  • tell your doctor and pharmacist if you are allergic to gemtuzumab ozogamicin, any other medications, or any of the ingredients in gemtuzumab ozogamicin injection. Ask your pharmacist for a list of the ingredients.

  • tell your doctor and pharmacist what prescription and nonprescription medications, vitamins, nutritional supplements, and herbal products you are taking or plan to take. Be sure to mention any of the following: amiodarone (Cordarone, Nexterone, Pacerone), anagrelide (Agrylin), chloroquine, chlorpromazine, cilostazol, citalopram (Celexa), disopyramide (Norpace), dofetilide (Tikosyn), donepezil (Aricept, in Namzaric), dronedarone (Multaq), escitalopram (Lexapro), flecainide (Tambocor), fluconazole (Diflucan), haloperidol (Haldol), ibutilide (Corvert), methadone (Methadose, Dolophine), ondansetron (Zuplenz, Sofran), pimozide (Orap), procainamide, quinidine (in Nuedexta), sotalol (Betapace, Sorine, Sotylize), and thioridazine. Your doctor may need to change the doses of your medications or monitor you carefully for side effects. Many other medications may also interact with gemtuzumab ozogamicin injection, so be sure to tell your doctor about all the medications you are taking, even those that do not appear on this list.

  • tell your doctor if you or anyone in your family has or has ever had long QT syndrome (condition that increases the risk of developing an irregular heartbeat that may cause fainting or sudden death), or if you have or have ever had or higher or lower than normal levels of sodium, potassium, calcium, or magnesium in your blood.

  • tell your doctor if you are pregnant, plan to become pregnant, or plan to father a child. You should not become pregnant while you are receiving gemtuzumab ozogamicin injection. You will need to have a negative pregnancy test before you begin receiving this medication. Use effective birth control during your treatment with gemtuzumab ozogamicin injection and for 6 months after your final dose. If you are a male and your partner can become pregnant, you should use effective birth control during your treatment and for 3 months after your final dose. If you or your partner become pregnant while receiving gemtuzumab ozogamicin injection, call your doctor.

  • tell your doctor if you are breastfeeding. You should not breastfeed while you are receiving gemtuzumab ozogamicin injection, and for 1 month after your final dose.

  • you should know that this medication may decrease fertility in men and women. Talk to your doctor about the risks of receiving gemtuzumab ozogamicin.

Unless your doctor tells you otherwise, continue your normal diet.

  • Gemtuzumab ozogamicin injection may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:

    • rash

    • diarrhea

    • constipation

    • nausea

    • vomiting

    • headache

    • pain

    • pain, swelling, or sores in mouth or throat

  • Some side effects can be serious. If you experience any of these symptoms or those listed in the IMPORTANT WARNING section, call your doctor immediately or get emergency medical treatment:

    • unusual or severe bleeding or bruising

    • cough, shortness of breath, or difficulty breathing

    • fast heartbeat

    • fever, chills, sore throat, or other signs of infection

  • Gemtuzumab ozogamicin injection may cause other side effects. Call your doctor if you have any unusual problems while receiving this medication.

  • If you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program online (http://www.fda.gov/Safety/MedWatch) or by phone (1-800-332-1088).

It is important for you to keep a written list of all of the prescription and nonprescription (over-the-counter) medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements. You should bring this list with you each time you visit a doctor or if you are admitted to a hospital. It is also important information to carry with you in case of emergencies.

Drug Interaction
Leflunomide Leflunomide The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Leflunomide.
Anagrelide Anagrelide The risk or severity of bleeding can be increased when Anagrelide is combined with Gemtuzumab ozogamicin.
Cilostazol Cilostazol The risk or severity of bleeding can be increased when Cilostazol is combined with Gemtuzumab ozogamicin.
Clopidogrel Clopidogrel The risk or severity of bleeding can be increased when Clopidogrel is combined with Gemtuzumab ozogamicin.
Estrogen and Progestin (Oral Contraceptives) Estrogen and Progestin (Oral Contraceptives) Conjugated estrogens may increase the thrombogenic activities of Gemtuzumab ozogamicin.
Mycophenolate Mycophenolate The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Mycophenolic acid.
Prednisone Prednisone The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Prednisone.
Tacrolimus Tacrolimus Tacrolimus may increase the immunosuppressive activities of Gemtuzumab ozogamicin.
Triamcinolone Triamcinolone The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Triamcinolone.
Interferon Beta-1b Injection Interferon Beta-1b Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Interferon beta-1b.
Interferon Gamma-1b Injection Interferon Gamma-1b Injection The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Gemtuzumab ozogamicin.
Methylprednisolone Injection Methylprednisolone Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Methylprednisolone.
Zidovudine Injection Zidovudine Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Zidovudine.
Cyclosporine Cyclosporine Gemtuzumab ozogamicin may increase the immunosuppressive activities of Cyclosporine.
Enoxaparin Injection Enoxaparin Injection The risk or severity of bleeding can be increased when Enoxaparin is combined with Gemtuzumab ozogamicin.
Hydroxychloroquine Hydroxychloroquine The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Hydroxychloroquine.
Temozolomide Temozolomide The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Temozolomide.
Anakinra Anakinra The risk or severity of adverse effects can be increased when Anakinra is combined with Gemtuzumab ozogamicin.
Linezolid Linezolid The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Linezolid.
Pentosan Polysulfate Pentosan Polysulfate The risk or severity of bleeding can be increased when Pentosan polysulfate is combined with Gemtuzumab ozogamicin.
Etanercept Injection Etanercept Injection The risk or severity of adverse effects can be increased when Etanercept is combined with Gemtuzumab ozogamicin.
Sirolimus Sirolimus The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Sirolimus.
Epirubicin Epirubicin The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Epirubicin.
Adalimumab Injection Adalimumab Injection The risk or severity of adverse effects can be increased when Adalimumab is combined with Gemtuzumab ozogamicin.
Glatiramer Injection Glatiramer Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Glatiramer.
Omalizumab Injection Omalizumab Injection The risk or severity of adverse effects can be increased when Omalizumab is combined with Gemtuzumab ozogamicin.
Darbepoetin Alfa Injection Darbepoetin Alfa Injection The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Gemtuzumab ozogamicin.
Infliximab Injection Infliximab Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Infliximab.
Natalizumab Injection Natalizumab Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Natalizumab.
Palifermin Palifermin The therapeutic efficacy of Palifermin can be decreased when used in combination with Gemtuzumab ozogamicin.
Peginterferon Alfa-2a Injection Peginterferon Alfa-2a Injection The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Gemtuzumab ozogamicin.
Peginterferon Alfa-2b (PEG-Intron) Peginterferon Alfa-2b (PEG-Intron) The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Gemtuzumab ozogamicin.
Abatacept Injection Abatacept Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Abatacept.
Imatinib Imatinib The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Imatinib.
Bevacizumab Injection Bevacizumab Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Bevacizumab.
Bortezomib Bortezomib The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Bortezomib.
Clofarabine Injection Clofarabine Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Clofarabine.
Hepatitis B Vaccine Hepatitis B Vaccine The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Gemtuzumab ozogamicin.
Influenza Vaccine, Inactivated or Recombinant Influenza Vaccine, Inactivated or Recombinant The therapeutic efficacy of Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Gemtuzumab ozogamicin.
Influenza Vaccine, Live Intranasal Influenza Vaccine, Live Intranasal The risk or severity of infection can be increased when Typhoid Vaccine Live is combined with Gemtuzumab ozogamicin.
Live Shingles (Zoster) Vaccine (ZVL) Live Shingles (Zoster) Vaccine (ZVL) The risk or severity of infection can be increased when Varicella Zoster Vaccine (Live/attenuated) is combined with Gemtuzumab ozogamicin.
Oxaliplatin Injection Oxaliplatin Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Oxaliplatin.
Rituximab Injection Rituximab Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Rituximab.
Cetuximab Injection Cetuximab Injection The risk or severity of adverse effects can be increased when Cetuximab is combined with Gemtuzumab ozogamicin.
Pemetrexed Injection Pemetrexed Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Pemetrexed.
Ranibizumab Injection Ranibizumab Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Ranibizumab.
Vorinostat Vorinostat The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Vorinostat.
Sorafenib Sorafenib The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Sorafenib.
Sunitinib Sunitinib The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Sunitinib.
Dasatinib Dasatinib The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Dasatinib.
Panitumumab Injection Panitumumab Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Panitumumab.
Azacitidine Injection Azacitidine Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Azacitidine.
Temsirolimus Temsirolimus The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Temsirolimus.
Nelarabine Injection Nelarabine Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Nelarabine.
Lenalidomide Lenalidomide The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Lenalidomide.
Nilotinib Nilotinib The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Nilotinib.
Bexarotene Bexarotene The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Bexarotene.
Budesonide Budesonide The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Budesonide.
Chloramphenicol Injection Chloramphenicol Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Chloramphenicol.
Decitabine Injection Decitabine Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Decitabine.
Arsenic Trioxide Injection Arsenic Trioxide Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Arsenic trioxide.
Mitoxantrone Injection Mitoxantrone Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Mitoxantrone.
Tretinoin Tretinoin The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Tretinoin.
Bendamustine Injection Bendamustine Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Bendamustine.
Certolizumab Injection Certolizumab Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Certolizumab pegol.
Ixabepilone Injection Ixabepilone Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Ixabepilone.
Irinotecan Injection Irinotecan Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Irinotecan.
Estramustine Estramustine The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Estramustine.
Alemtuzumab Injection (Chronic Lymphocytic Leukemia) Alemtuzumab Injection (Chronic Lymphocytic Leukemia) The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Alemtuzumab.
Dexrazoxane Injection Dexrazoxane Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Dexrazoxane.
Ibritumomab Injection Ibritumomab Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Ibritumomab tiuxetan.
Prasugrel Prasugrel The risk or severity of bleeding can be increased when Prasugrel is combined with Gemtuzumab ozogamicin.
Everolimus Everolimus The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Everolimus.
Pralatrexate Injection Pralatrexate Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Pralatrexate.
Topotecan Topotecan The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Topotecan.
Ofatumumab Injection (Chronic Lymphocytic Leukemia) Ofatumumab Injection (Chronic Lymphocytic Leukemia) The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Ofatumumab.
Golimumab Injection Golimumab Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Golimumab.
Pazopanib Pazopanib The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Pazopanib.
Denosumab Injection Denosumab Injection The risk or severity of adverse effects can be increased when Denosumab is combined with Gemtuzumab ozogamicin.
Dabigatran Dabigatran The risk or severity of bleeding can be increased when Dabigatran is combined with Gemtuzumab ozogamicin.
Tocilizumab Injection Tocilizumab Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Tocilizumab.
Fingolimod Fingolimod Gemtuzumab ozogamicin may increase the immunosuppressive activities of Fingolimod.
Eribulin Injection Eribulin Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Eribulin.
Cabazitaxel Injection Cabazitaxel Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Cabazitaxel.
Ustekinumab Injection Ustekinumab Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Ustekinumab.
Ipilimumab Injection Ipilimumab Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Ipilimumab.
Denileukin Diftitox Injection Denileukin Diftitox Injection The risk or severity of adverse effects can be increased when Aldesleukin is combined with Gemtuzumab ozogamicin.
Sipuleucel-T Injection Sipuleucel-T Injection The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Gemtuzumab ozogamicin.
Belimumab Injection Belimumab Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Belimumab.
Busulfan Injection Busulfan Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Busulfan.
Roflumilast Roflumilast Roflumilast may increase the immunosuppressive activities of Gemtuzumab ozogamicin.
Cyclophosphamide Injection Cyclophosphamide Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Cyclophosphamide.
Rivaroxaban Rivaroxaban The risk or severity of bleeding can be increased when Rivaroxaban is combined with Gemtuzumab ozogamicin.
Ticagrelor Ticagrelor The risk or severity of bleeding can be increased when Ticagrelor is combined with Gemtuzumab ozogamicin.
Brentuximab Vedotin Injection Brentuximab Vedotin Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Brentuximab vedotin.
Ruxolitinib Ruxolitinib The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Ruxolitinib.
Belatacept Injection Belatacept Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Belatacept.
Basiliximab Injection Basiliximab Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Basiliximab.
Melphalan Injection Melphalan Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Melphalan.
Eculizumab Injection Eculizumab Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Eculizumab.
Fondaparinux Injection Fondaparinux Injection The risk or severity of bleeding can be increased when Fondaparinux is combined with Gemtuzumab ozogamicin.
Pertuzumab Injection Pertuzumab Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Pertuzumab.
Carfilzomib Injection Carfilzomib Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Carfilzomib.
Iloprost Iloprost The risk or severity of bleeding can be increased when Iloprost is combined with Gemtuzumab ozogamicin.
Bosutinib Bosutinib The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Bosutinib.
Corticotropin, Repository Injection Corticotropin, Repository Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Corticotropin.
Teriflunomide Teriflunomide The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Teriflunomide.
Icosapent Ethyl Icosapent Ethyl The risk or severity of bleeding can be increased when Icosapent ethyl is combined with Gemtuzumab ozogamicin.
Tofacitinib Tofacitinib Gemtuzumab ozogamicin may increase the immunosuppressive activities of Tofacitinib.
Dimethyl Fumarate Dimethyl Fumarate The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Dimethyl fumarate.
Ponatinib Ponatinib The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Ponatinib.
Pomalidomide Pomalidomide The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Pomalidomide.
Ado-trastuzumab Emtansine Injection Ado-trastuzumab Emtansine Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Trastuzumab emtansine.
Apixaban Apixaban The risk or severity of bleeding can be increased when Apixaban is combined with Gemtuzumab ozogamicin.
Ibrutinib Ibrutinib The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Ibrutinib.
Obinutuzumab Injection Obinutuzumab Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Obinutuzumab.
Apremilast Apremilast The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Apremilast.
Ramucirumab Injection Ramucirumab Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Ramucirumab.
Siltuximab Injection Siltuximab Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Siltuximab.
Vedolizumab Injection Vedolizumab Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Vedolizumab.
Belinostat Injection Belinostat Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Belinostat.
Idelalisib Idelalisib The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Idelalisib.
Vorapaxar Vorapaxar The risk or severity of bleeding can be increased when Vorapaxar is combined with Gemtuzumab ozogamicin.
Dulaglutide Injection Dulaglutide Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Dulaglutide.
Pembrolizumab Injection Pembrolizumab Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Pembrolizumab.
Edoxaban Edoxaban The risk or severity of bleeding can be increased when Edoxaban is combined with Gemtuzumab ozogamicin.
Nivolumab Injection Nivolumab Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Nivolumab.
Peginterferon Beta-1a Injection Peginterferon Beta-1a Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Peginterferon beta-1a.
Olaparib Olaparib The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Olaparib.
Blinatumomab Injection Blinatumomab Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Blinatumomab.
Pirfenidone Pirfenidone The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Pirfenidone.
Secukinumab Injection Secukinumab Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Secukinumab.
Palbociclib Palbociclib The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Palbociclib.
Panobinostat Panobinostat The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Panobinostat.
Dinutuximab Injection Dinutuximab Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Dinutuximab.
Alirocumab Injection Alirocumab Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Alirocumab.
Prednisolone Prednisolone The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Prednisolone.
Evolocumab Injection Evolocumab Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Evolocumab.
Mepolizumab Injection Mepolizumab Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Mepolizumab.
Trabectedin Injection Trabectedin Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Trabectedin.
Elotuzumab Injection Elotuzumab Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Elotuzumab.
Daratumumab Injection Daratumumab Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Daratumumab.
Necitumumab Injection Necitumumab Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Necitumumab.
Dexamethasone Injection Dexamethasone Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Dexamethasone.
Reslizumab Injection Reslizumab Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Reslizumab.
Defibrotide Injection Defibrotide Injection The risk or severity of bleeding can be increased when Defibrotide is combined with Gemtuzumab ozogamicin.
Ixekizumab Injection Ixekizumab Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Ixekizumab.
Atezolizumab Injection Atezolizumab Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Atezolizumab.
Olaratumab Injection Olaratumab Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Olaratumab.
Bezlotoxumab Injection Bezlotoxumab Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Bezlotoxumab.
Avelumab Injection Avelumab Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Avelumab.
Brodalumab Injection Brodalumab Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Brodalumab.
Dupilumab Injection Dupilumab Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Dupilumab.
Deflazacort Deflazacort The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Deflazacort.
Ocrelizumab Injection Ocrelizumab Injection Ocrelizumab may increase the immunosuppressive activities of Gemtuzumab ozogamicin.
Durvalumab Injection Durvalumab Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Durvalumab.
Sarilumab Injection Sarilumab Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Sarilumab.
Guselkumab Injection Guselkumab Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Guselkumab.
Inotuzumab Ozogamicin Injection Inotuzumab Ozogamicin Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Inotuzumab ozogamicin.
Betrixaban Betrixaban The risk or severity of bleeding can be increased when Betrixaban is combined with Gemtuzumab ozogamicin.
Benralizumab Injection Benralizumab Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Benralizumab.
Ibalizumab-uiyk Injection Ibalizumab-uiyk Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Ibalizumab.
Penicillamine Penicillamine The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Penicillamine.
Tildrakizumab-asmn injection Tildrakizumab-asmn injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Tildrakizumab.
Erenumab-aooe Injection Erenumab-aooe Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Erenumab.
Baricitinib Baricitinib The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Baricitinib.
Burosumab-twza Injection Burosumab-twza Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Burosumab.
Cemiplimab-rwlc Injection Cemiplimab-rwlc Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Cemiplimab.
Galcanezumab-gnlm Injection Galcanezumab-gnlm Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Galcanezumab.
Mogamulizumab-kpkc Injection Mogamulizumab-kpkc Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Mogamulizumab.
Methoxy Polyethylene Glycol-Epoetin Beta Injection Methoxy Polyethylene Glycol-Epoetin Beta Injection The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Gemtuzumab ozogamicin.
Paclitaxel (with albumin) Injection Paclitaxel (with albumin) Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Paclitaxel.
Ravulizumab-cwvz Injection Ravulizumab-cwvz Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Ravulizumab.
Emapalumab-lzsg Injection Emapalumab-lzsg Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Emapalumab.
Romosozumab-aqqg Injection Romosozumab-aqqg Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Romosozumab.
Siponimod Siponimod The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Siponimod.
Caplacizumab-yhdp Injection Caplacizumab-yhdp Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Caplacizumab.
Risankizumab-rzaa Injection Risankizumab-rzaa Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Risankizumab.
Cladribine Cladribine The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Cladribine.
Polatuzumab vedotin-piiq Injection Polatuzumab vedotin-piiq Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Polatuzumab vedotin.
Pexidartinib Pexidartinib Gemtuzumab ozogamicin may increase the hepatotoxic activities of Pexidartinib.
Brolucizumab-dbll Injection Brolucizumab-dbll Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Brolucizumab.
Fam-trastuzumab deruxtecan-nxki Injection Fam-trastuzumab deruxtecan-nxki Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Trastuzumab deruxtecan.
Isatuximab-irfc Injection Isatuximab-irfc Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Isatuximab.
Teprotumumab-trbw Injection Teprotumumab-trbw Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Teprotumumab.
Ozanimod Ozanimod The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Ozanimod.
Sacituzumab govitecan-hziy Injection Sacituzumab govitecan-hziy Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Sacituzumab govitecan.
Luspatercept-aamt Injection Luspatercept-aamt Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Luspatercept.
Belantamab Mafodotin-blmf Injection Belantamab Mafodotin-blmf Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Belantamab mafodotin.
Tafasitamab-cxix Injection Tafasitamab-cxix Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Tafasitamab.
Margetuximab-cmkb Injection Margetuximab-cmkb Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Margetuximab.
Evinacumab-dgnb Injection Evinacumab-dgnb Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Evinacumab.
Aducanumab-avwa Injection Aducanumab-avwa Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Aducanumab.
Anifrolumab-fnia Injection Anifrolumab-fnia Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Anifrolumab.
Indomethacin Indomethacin The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Indomethacin.
Hydroxyurea Hydroxyurea The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Hydroxyurea.
Floxuridine Floxuridine The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Floxuridine.
Methotrexate Injection Methotrexate Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Methotrexate.
Carmustine Carmustine The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Carmustine.
Procarbazine Procarbazine The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Procarbazine.
Thioguanine Thioguanine The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Tioguanine.
Bleomycin Bleomycin The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Bleomycin.
Azathioprine Azathioprine The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Azathioprine.
Sulfasalazine Sulfasalazine The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Sulfasalazine.
Lomustine Lomustine The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Lomustine.
Doxorubicin Doxorubicin The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Doxorubicin.
Cytarabine Cytarabine The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Cytarabine.
Mechlorethamine Mechlorethamine The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Mechlorethamine.
Dactinomycin Dactinomycin The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Dactinomycin.
Carbamazepine Carbamazepine The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Carbamazepine.
Warfarin Warfarin The risk or severity of bleeding can be increased when Warfarin is combined with Gemtuzumab ozogamicin.
Daunorubicin Daunorubicin The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Daunorubicin.
Sulfinpyrazone Sulfinpyrazone The risk or severity of bleeding can be increased when Sulfinpyrazone is combined with Gemtuzumab ozogamicin.
Chlorothiazide Chlorothiazide The risk or severity of neutropenia and thrombocytopenia can be increased when Chlorothiazide is combined with Gemtuzumab ozogamicin.
Mitomycin Mitomycin The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Mitomycin.
Methimazole Methimazole The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Methimazole.
Propylthiouracil Propylthiouracil The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Propylthiouracil.
Methyclothiazide Methyclothiazide The risk or severity of neutropenia and thrombocytopenia can be increased when Methyclothiazide is combined with Gemtuzumab ozogamicin.
Hydrochlorothiazide Hydrochlorothiazide The risk or severity of neutropenia and thrombocytopenia can be increased when Hydrochlorothiazide is combined with Gemtuzumab ozogamicin.
Mercaptopurine Mercaptopurine The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Mercaptopurine.
Allopurinol Allopurinol The risk or severity of adverse effects can be increased when Allopurinol is combined with Gemtuzumab ozogamicin.
Fluorouracil Injection Fluorouracil Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Fluorouracil.
Colchicine Colchicine The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Colchicine.
Dacarbazine Dacarbazine The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Dacarbazine.
Bacillus Calmette-Guerin (BCG) Vaccine Bacillus Calmette-Guerin (BCG) Vaccine The risk or severity of infection can be increased when Bacillus calmette-guerin substrain tice live antigen is combined with Gemtuzumab ozogamicin.
Thiotepa Injection Thiotepa Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Thiotepa.
Vincristine Injection Vincristine Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Vincristine.
Dipyridamole Dipyridamole The risk or severity of bleeding can be increased when Dipyridamole is combined with Gemtuzumab ozogamicin.
Vinblastine Vinblastine The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Vinblastine.
Aspirin Aspirin The risk or severity of bleeding can be increased when Acetylsalicylic acid is combined with Gemtuzumab ozogamicin.
Chlorambucil Chlorambucil The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Chlorambucil.
Cisplatin Injection Cisplatin Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Cisplatin.
Streptozocin Streptozocin The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Streptozocin.
Etoposide Etoposide The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Etoposide.
Pentoxifylline Pentoxifylline The risk or severity of bleeding can be increased when Pentoxifylline is combined with Gemtuzumab ozogamicin.
Interferon Alfa-2b Injection Interferon Alfa-2b Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Interferon alfa-2b.
Clozapine Clozapine The risk or severity of neutropenia can be increased when Gemtuzumab ozogamicin is combined with Clozapine.
Idarubicin Idarubicin The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Idarubicin.
Fludarabine Injection Fludarabine Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Fludarabine.
Pentostatin Injection Pentostatin Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Pentostatin.
Epoetin Alfa, Injection Epoetin Alfa, Injection The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Gemtuzumab ozogamicin.
Teniposide Injection Teniposide Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Teniposide.
Vinorelbine Injection Vinorelbine Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Vinorelbine.
Carboplatin Injection Carboplatin Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Carboplatin.
Ifosfamide Injection Ifosfamide Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Ifosfamide.
Pegaspargase Injection Pegaspargase Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Pegaspargase.
Ticlopidine Ticlopidine The risk or severity of bleeding can be increased when Ticlopidine is combined with Gemtuzumab ozogamicin.
Dalteparin Injection Dalteparin Injection The risk or severity of bleeding can be increased when Dalteparin is combined with Gemtuzumab ozogamicin.
Gemcitabine Injection Gemcitabine Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Gemcitabine.
Docetaxel Injection Docetaxel Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Docetaxel.
Palivizumab Injection Palivizumab Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Palivizumab.
Capecitabine Capecitabine The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Capecitabine.
Trastuzumab Injection Trastuzumab Injection Trastuzumab may increase the neutropenic activities of Gemtuzumab ozogamicin.
Thalidomide Thalidomide The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Thalidomide.

Content provided by: AHFS® Patient Medication Information™. © Copyright, 2021. The American Society of Health-System Pharmacists